TAILIEUCHUNG - FERTILITY ISSUES IN CHILDHOOD CANCER TREATMENT

Antioxidants are man-made or natural substances that may prevent or delay some types of cell damage. Diets high in vegetables and fruits, which are good sources of antioxidants, have been found to be healthy; however, research has not shown antioxidant supplements to be beneficial in preventing diseases. Examples of antioxidants include vitamins C and E, selenium, and carotenoids, such as beta-carotene, lycopene, lutein, and zeaxanthin. This fact sheet provides basic information about antioxidants, summarizes what the science says about antioxidants and health, and suggests sources for additional information | Fertility Issues in Childhood Cancer Treatment Information and Resources for our Families in the LPCH Pediatric Oncology Department Lucile Salter Packard Children s Hospital 725 Welch Rd. Palo Alto CA 94304 I. Introduction II. What are possible effects of cancer therapies on my child s reproductive system III. Questions to ask your doctor before therapy IV. Factors that affect the risk of infertility a. Common cancers in childhood and adolescence b. Chemotherapy c. Radiotherapy d. Information for hematology patients receiving bone marrow transplants V. Before therapy Options for protecting fertility VI. After therapy Important health and social issues VII. Additional resources VIII. Important contact information Page 2 Introduction After your child has been diagnosed with cancer survival is your first concern. While medical advances have helped most children survive cancer treatments for cancer may cause side effects. Infertility or the inability to have children is a side effect of some cancer therapies. Even though your child s future fertility may not be a main concern at the time of diagnosis there are ways to help protect their chances to have children in the future. It is important to check into these options before starting treatment. It is also important to be aware of the effects of cancer treatment on future child-bearing to know what to expect after completion of therapy. The goal of this booklet is to offer the most up-to-date information on both the infertility risk based on your child s disease and treatment as well as options to save fertility that are available at Lucile Salter Packard Children s Hospital and in the nearby area. We hope that the information in this booklet will help you to understand your child s risks and options so that you can make a decision that is best for your family. Please be sure to talk with your child s health care provider about any questions or concerns. Acknowledgements s FertileHope Stanford School of Medicine .

• Y học thường thức
• Prostate Cancer
• Health Perspective
• Chemical Residues
• Venous Thromboembolism
• Certain Groups of Patients
• Venous Thromboembolism
• Radiation therapy
• Clinical management
• Metastatic prostate cancer
• Localized prostate cancer
• BMC Cancer
• Initial prostate biopsy
• Diagnose prostate cancer
• Probability density functions
• Adenocarcinoma of prostate
• Androgen independent prostatic cancer
• Docetaxel resistance
• Anti neoplastic agent resistance
• Doctor of Medicine summary
• Application of 12 core prostate biopsy
• Transrectal ultrasound guidance
• Diagnosis of prostate cancer
• Castration resistant prostate cancer
• Androgen concentrations
• Measure testosterone
• Chromosomal instability
• Prostate needle biopsies
• Amino acids
• Prostate cancer biomarkers
• Prostate specific antigen
• Diagnostic biomarkers
• Biological fluids
• Metastatic castrate resistant
• Prostate specific antigen while
• Health implications
• GnRH antagonist
• GnRH agonist
• Neoadjuvant androgen deprivation therapy
• Quality of life
• Non invasive biomarkers
• Benign prostate hyperplasia
• Diagnostic dilemma
• Prostate specific antigen doubling time
• Personalized peptide vaccine
• Surrogate marker
• Overall survival
• Recombinant antibody
• Human dendritic cells
• The medical doctoral thesis
• Histopathological fearures immunohistochemistry
• Methylation of rassf1a gene in prostate cancer
• Rassf1a gene in prostate cancer
• Istopathological features in prostate carcinoma
• Genome Biology
• DNA methylation
• Slow growing prostate cancer
• Prostate specifc antigen decline rate per week
• Degree of prostatic collapse
• Tissue signal rate of prostate
• Prostatitis disease
• Endocrine therapy
• Hormone treatment
• Cancer patients treated
• Cancer surveillance series
• Cell migration
• Cell invasion
• Above mentioned cytokines
• High cancer related deaths
• Prostate intraepithelial neoplasia
• PSGR protein
• Cancer cell growth
• Regulatory T cell
• Platinum based chemotherapy
• Multiple cancer cell lines
• Anti prostate cancer
• Frequently diagnosed cancer
• PC3 cell migration
• Human prostate cancer
• Breast and prostate cancer
• Expression of NRIF3
• Breast cancer
• Transcriptional repressor
• Targeted imaging
• Orthotopic prostate cancer
• Clinical transformable
• Photoacoustic imaging system
• Meta analysis
• Precise mechanism
• Tumor cells
• Recurrent prostate cancer
• Salvage radiation therapy
• High risk prostate cancer
• Primary hypothesis
• Protein tyrosine phosphatase non receptor 12
• Quantitative Gleason grade